Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era

PURPOSE: The dose intensity of doxorubicin (DID) is important to the survival of diffuse large B cell lymphoma (DLBCL) patients. However, due to expected toxicities, most elderly patients cannot receive full doses of anthracyclines. The purpose of this study was to evaluate the effect of DID on the...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Res Treat
Main Authors: Ha, Hyerim, Keam, Bhumsuk, Kim, Tae Min, Jeon, Yoon Kyung, Lee, Se-Hoon, Kim, Dong-Wan, Kim, Chul Woo, Heo, Dae Seog
Format: Artigo
Sprog:Inglês
Udgivet: Korean Cancer Association 2016
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4720063/
https://ncbi.nlm.nih.gov/pubmed/25865654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2014.339
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker